Certificate PL-26-00031 · EPO (Erythropoietin) 3,000 IU · lot PL-2609-031
VerifyCertificate page
PrymaLab
PrymaLab
PrymaLab Analytical · In-house laboratory
3705 Music Branch Rd, Ashland, KY 41102 · +1 (606) 465-9063 · prymalab.net
Certificate no.
PL-26-00031
Verification key
VGPQQ77C
Scan or enter both at
prymalab.net/testing/verify

Certificate of Analysis · Lot release

EPO (Erythropoietin) 3,000 IU

Lot PL-2609-031 · Lyophilized powder · Label claim 3000 IU/vial (≈ 25 µg glycoprotein)
Tested in-house by PrymaLab
In-house analytical result,
not an independent third-party test
Lot / batch number
PL-2609-031
Date made
2026-09-18
Date of analysis
2026-09-19
Date issued
2026-10-03
Retest / expiry
2028-09-18
Units in lot / sampled
250 / 2
Storage
2–8 °C, dark; do not freeze
Certificate type
Lot COA, 2 pages
Compound
Erythropoietin (rhEPO)
Recombinant human erythropoietin, epoetin class
CAS number
11096-26-7
Molecular formula
C809H1301N229O240S5 (165-residue protein core)
Theoretical mass (avg.)
About 30.4 kDa glycoform average; 18.2 kDa protein core
Structure
165-residue mature human EPO (UniProt P01588 residues 28–192; C-terminal Arg166 removed), CHO-expressed; N-glycans at Asn24, Asn38 and Asn83, O-glycan at Ser126; disulfides Cys7–Cys161 and Cys29–Cys33.
Purity · RP-HPLC, area %
99.18%
Specification 99.0% • main peak (glycoform cluster) at 7.18 min
Identity · Observed Mass
30,412 Da
Deconvoluted glycoform centroid • theoretical 30.4 kDa average
Overall conclusion
PASS
Meets every specification for the tests performed
TestMethodSpecificationResultConclusion
AppearanceVisual inspectionWhite lyophilized powder or cakeWhite lyophilized cakePASS
Identity (mass)LC-MS, ESI positiveWithin glycoform envelope30,412 Da centroid (CHO glycoforms 28–34 kDa)PASS
PurityRP-HPLC, UV 214 nm, area%99.0%99.18%PASS
Largest impurityRP-HPLC, area%1.0%0.42% at 6.44 minPASS
Water contentKarl Fischer5.0%1.9%PASS
Bacterial endotoxinLAL, kinetic≤ 5.0 EU/mg0.27 EU/mgPASS
Sterility / bioburdenUSP <71>, membrane filtrationNo growth after 14 daysNo growth; conformsPASS

1HPLC chromatogram

Data file: EPO_PL-2609-031_20260919_01 · Column C18, 150 × 4.6 mm · UV 214 nm
0 150 300 mAU 024 6810 Time (min) EPO — 99.18% @ 7.18 min 0.42% @ 6.44 0.25% @ 7.74 0.15% @ 8.32
Baseline uncropped; main peak (intact monomer glycoform cluster) and impurities labeled with retention times. Peak table on page 2.
PrymaLab
PrymaLab
Certificate of Analysis · continued
EPO (Erythropoietin) 3,000 IU · Lot PL-2609-031 · Certificate PL-26-00031
Lot PL-2609-031
Method, peak table and approval

2HPLC method · EPO_PL-2609-031_20260919_01

Instrument
Waters Alliance e2695, SN E2695B742
Data System
Empower 3, Build 3471
Detector
Waters 2998 PDA
Detection Wavelength
214 nm
Column
C18, 150 × 4.6 mm, 3.5 µm
Column Part / Serial
186003326 / USHX18211
Mobile Phase A
0.1% TFA in water
Mobile Phase B
0.1% TFA in MeCN
Flow Rate
1.0 mL/min
Column Temperature
30 °C
Injection Volume
20 µL
Run Time
10 min
Sample Diluent
Water, 0.1% TFA
Sample Concentration
0.2 mg/mL (pooled composite)
Blank Injected
Yes
Reference Standard
In-house rhEPO reference, lot PL-RS-EPO-01, RT 7.16 min (glycoform cluster)

3Gradient program

Time (min)% A% B
0.0955
3.0955
7.05545
8.02080
9.02080
10.0955

4Peak table

PeakRT (min)AreaArea %
16.4418,0600.42
27.184,264,74099.18
37.7410,7500.25
48.326,4500.15
Total4,300,000100.00
Threshold 0.05% area · Blank subtracted: Y · Purity = main peak area ÷ total integrated area × 100, to two decimals; main peak shaded.

5Identity by mass spectrometry

Instrument
Waters Acquity SQD
Ionization / Mode
ESI, positive
Observed m/z (charge)
1521.6 (20+ [M+20H]) · 1217.5 (25+ [M+25H])
Deconvoluted Mass
30,412 Da (glycoform centroid)
Theoretical Mass
30,400 Da average glycoform (18.2 kDa protein core)
Difference
Within CHO glycoform envelope (28–34 kDa)
Data File
EPO_PL-2609-031_MS_20260919_01
Acceptance
Within glycoform envelope

6Additional tests

TestPerformed byDateReport / file
Water contentPrymaLab2026-09-20RPT-KF-PL-2609-031
EndotoxinPrymaLab2026-09-21RPT-ET-PL-2609-031
SterilityPrymaLab2026-10-02RPT-ST-PL-2609-031
A test with no row here was not performed on this lot. Outside-laboratory reports, when used, are attached and named below.

7Review and approval

D. Reynolds
Analyst · performed the testing
Date: 2026-09-19
S. Calloway
Reviewer · checked against raw data
Date: 2026-10-02
M. Phelps
Lab Director · approved for release
Date: 2026-10-03